↓ Skip to main content

Dove Medical Press

Canagliflozin in the treatment of type 2 diabetes: an evidence-based review of its place in therapy

Overview of attention for article published in Core Evidence, March 2017
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (52nd percentile)

Mentioned by

policy
1 policy source

Citations

dimensions_citation
6 Dimensions

Readers on

mendeley
69 Mendeley
Title
Canagliflozin in the treatment of type 2 diabetes: an evidence-based review of its place in therapy
Published in
Core Evidence, March 2017
DOI 10.2147/ce.s109654
Pubmed ID
Authors

Thomas Karagiannis, Eleni Bekiari, Apostolos Tsapas

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 69 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 69 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 13 19%
Student > Master 11 16%
Other 8 12%
Student > Ph. D. Student 6 9%
Researcher 5 7%
Other 12 17%
Unknown 14 20%
Readers by discipline Count As %
Medicine and Dentistry 29 42%
Pharmacology, Toxicology and Pharmaceutical Science 14 20%
Nursing and Health Professions 3 4%
Environmental Science 2 3%
Biochemistry, Genetics and Molecular Biology 2 3%
Other 3 4%
Unknown 16 23%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 17 April 2019.
All research outputs
#7,642,184
of 23,270,775 outputs
Outputs from Core Evidence
#35
of 75 outputs
Outputs of similar age
#122,457
of 311,917 outputs
Outputs of similar age from Core Evidence
#2
of 2 outputs
Altmetric has tracked 23,270,775 research outputs across all sources so far. This one is in the 44th percentile – i.e., 44% of other outputs scored the same or lower than it.
So far Altmetric has tracked 75 research outputs from this source. They receive a mean Attention Score of 4.9. This one is in the 25th percentile – i.e., 25% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 311,917 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 52% of its contemporaries.
We're also able to compare this research output to 2 others from the same source and published within six weeks on either side of this one.